Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy:: Results of a prospective trial and preliminary guidelines for standardized contours

被引:382
作者
Viswanathan, Akila N.
Dimopoulos, Johannes
Kirisits, Christian
Berger, Daniel
Potter, Richard
机构
[1] Med Univ Vienna, Dept Radiotherapy & Radiobiol, A-1090 Vienna, Austria
[2] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2007年 / 68卷 / 02期
关键词
cervical cancer; brachytherapy; computed tomography; magnetic resonance imaging;
D O I
10.1016/j.ijrobp.2006.12.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To compare the contours and dose-volume histograms (DVH) of the tumor and organs at risk (OAR) with computed tomography (CT) vs. magnetic resonance imaging (MRI) in cervical cancer brachytherapy. Methods and Materials: Ten patients underwent both MRI and CT after applicator insertion. The dose received by at least 90% of the volume (D-90), the minimal target dose (D-100), the volume treated to the prescription dose or greater for tumor for the high-risk (HR) and intermediate-risk (IR) clinical target volume (CTV) and the dose to 0.1 cm(3), 1 cm(3), and 2 cm(3) for the OARs were evaluated. A standardized approach to contouring on CT (CTStd) was developed, implemented (HR- and IR-CTVCTStd), and compared with the MRI contours. Results: Tumor height, thickness, and total volume measurements, as determined by either CT or CTStd were not significantly different compared with the MRI volumes. In contrast, the width measurements differed in HR-CTVCTStd (p = 0.05) and IR-CTVCTStd(p = 0.01). For the HR-CTVCTStd, this resulted in statistically significant differences in the volume treated to the prescription dose or greater (MRI, 96% vs. CTStd, 86 %, p = 0.01), D-100 (MRI, 5.4 vs. CTStd, 3.4, p < 0.01), and D-90 (MRI, 8.7 vs. CTStd, 6.7, p < 0.01). Correspondingly, the IR-CTV DVH values on MRI vs. CTStd, differed in the D-100 (MRI, 3.0 vs. CTStd, 2.2, p = 0.01) and D-90 (MRI, 5.6 vs. CTStd, 4.6, p = 0.02). The MRI and CT DVH values of the dose to 0.1 cm(3), 1 cm(3), and 2 cm(3) for the OARs were similar. Conclusion: Computed tomography-based or MRI-based scans at brachytherapy are adequate for OAR DVH analysis. However, CT tumor contours can significantly overestimate the tumor width, resulting in significant differences in the D90, D100, and volume treated to the prescription dose or greater for the HR-CTV compared with that using MRI. MRI remains the standard for CTV definition. (C) 2007 Elsevier Inc.
引用
收藏
页码:491 / 498
页数:8
相关论文
共 33 条
  • [1] A COMPARATIVE-STUDY OF COMPUTERIZED-TOMOGRAPHY, MAGNETIC-RESONANCE-IMAGING, AND CLINICAL STAGING FOR THE DETECTION OF EARLY CERVIX CANCER
    BRODMAN, M
    FRIEDMAN, F
    DOTTINO, P
    JANUS, C
    PLAXE, S
    COHEN, C
    [J]. GYNECOLOGIC ONCOLOGY, 1990, 36 (03) : 409 - 412
  • [2] A CT BASED DOSIMETRY SYSTEM FOR INTRACAVITARY THERAPY IN CARCINOMA OF THE CERVIX
    COLTART, RS
    NETHERSELL, ABW
    THOMAS, S
    DIXON, AK
    [J]. RADIOTHERAPY AND ONCOLOGY, 1987, 10 (04) : 295 - 305
  • [3] Systematic evaluation of MRI findings in different stages of treatment of cervical cancer:: Potential of MRI on delineation of target, pathoanatomic structures, and organs at risk
    Dimopoulos, JCA
    Schard, G
    Berger, D
    Lang, S
    Goldner, G
    Helbich, T
    Pötter, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (05): : 1380 - 1388
  • [4] THE RELATIONSHIP BETWEEN BRACHYTHERAPY DOSE AND OUTCOME IN PATIENTS WITH BULKY ENDOCERVICAL TUMORS TREATED WITH RADIATION ALONE
    EIFEL, PJ
    THOMS, WW
    SMITH, TL
    MORRIS, M
    OSWALD, MJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 28 (01): : 113 - 118
  • [5] CT-guided interstitial implantation of gynecologic malignancies
    Erickson, B
    Albano, K
    Gillin, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (03): : 699 - 709
  • [6] Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects
    Fellner, C
    Pötter, R
    Knocke, TH
    Wambersie, A
    [J]. RADIOTHERAPY AND ONCOLOGY, 2001, 58 (01) : 53 - 62
  • [7] CT ANATOMY OF THE FEMALE PELVIS - A 2ND LOOK
    FOSHAGER, MC
    WALSH, JW
    [J]. RADIOGRAPHICS, 1994, 14 (01) : 51 - 64
  • [8] Aspects of MR image distortions in radiotherapy treatment planning
    Fransson, A
    Andreo, P
    Pötter, R
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2001, 177 (02) : 59 - 73
  • [9] Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group* (I):: concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV
    Haie-Meder, C
    Pötter, R
    Van Limbergen, E
    Briot, E
    De Brabandere, M
    Dimopoulos, J
    Dumas, I
    Hellebust, TP
    Kirisits, C
    Lang, SF
    Muschitz, S
    Nevinson, J
    Nulens, A
    Petrow, P
    Wachter-Gerstner, N
    [J]. RADIOTHERAPY AND ONCOLOGY, 2005, 74 (03) : 235 - 245
  • [10] DOSIMETRY OF INTRACAVITARY PLACEMENTS FOR UTERINE AND CERVICAL-CARCINOMA - RESULTS OF ORTHOGONAL FILM, TLD, AND CT-ASSISTED TECHNIQUES
    KAPP, KS
    STUECKLSCHWEIGER, GF
    KAPP, DS
    HACKL, AG
    [J]. RADIOTHERAPY AND ONCOLOGY, 1992, 24 (03) : 137 - 146